The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

Just 15 minutes per day of fast walking reduced the risk of premature death in a low-income and predominantly Black U.S. population.

The video is produced by the research team to explain the results of the study. Findings from the largest genetic analysis of stuttering are published in Nature Genetics; they point to 48 genes associated with stuttering and highlight neurological pathways of risk.

The research characterizes the molecular “cargo” of circulating extracellular vesicles in obesity and links the findings to human genetic approaches to identify potential therapeutic targets for metabolic disease.

The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume.